La escala Strength and Difficulties Questionnaire (SDQ) como predictora del TDAH: comportamiento de las subescalas SDQ respecto a las dimensiones "Hiperactividad/Impulsividad" e "Inatención" en una muestra clínica

Introducción: La escala Strength and Difficulties Questionnaire (SDQ) es una herramienta de cribado clínico para infancia y adolescencia ampliamente utilizada internacionalmente en la clínica y en la investigación. Objetivo: El objetivo de este estudio es explorar la relación entre los diferentes índices de la escala SDQ y la puntuación en las dimensiones "Hiperactividad/Impulsividad" e "inatención" en una escala específica de TDAH. Método: Padres y profesores/as de una muestra de 212 niños/as de entre 6 y 16 años con un diagnóstico previo de TDAH, completaron las escalas SDQ y ADHD-RS-IV. Resultados: Se confirmó la relación significativa entre la dimensión "Hiperactividad" de la escala SDQ y ambas dimensiones del TDAH. Sin embargo, otros índices de la escala SDQ mostraron también relación con ambas dimensiones, diferenciando esta relación según el informador y la dimensión clínica. Para la familia, la "hiperactividad/impulsividad" estaba también relacionada con puntuaciones elevadas en la subescala "Problemas de conducta", mientras que la "inatención" lo estaba con "síntomas emocionales". Conclusiones: Estos resultados sugieren la posibilidad de valorar las puntuaciones en otros índices de la escala SCT para aumentar la sensibilidad de la escala a los diferentes perfiles clínicos del TDAH.

Adherence to antiretroviral therapy and its determinants among persons living with HIV/AIDS in Bayelsa state, Nigeria

Background: A high level of adherence is required to achieve the desired outcomes of antiretroviral therapy. There is paucity of information about adherence to combined antiretroviral therapy in Bayelsa State of southern Nigeria. Objectives: The objectives of the study were to determine the level of adherence to combined antiretroviral therapy among the patients, evaluate the improvement in their immune status and identify reasons for sub-optimal adherence to therapy. Methods: The cross-sectional study involved administration of an adapted and pretested questionnaire to 601 consented patients attending the two tertiary health institutions in Bayesla State, Nigeria: The Federal Medical Centre, Yenagoa and the Niger-Delta University Teaching Hospital Okolobiri. The tool was divided into various sections such as socio-demographic data, HIV knowledge and adherence to combined antiretroviral therapy. Information on the patient's CD4+ T cells count was retrieved from their medical records. Adherence was assessed by asking patients to recall their intake of prescribed doses in the last fourteen days and subjects who had 95-100% of the prescribed antiretroviral drugs were considered adherent. Results: Three hundred and forty eight (57.9%) of the subjects were females and 253 (42.1%) were males. The majority of them, 557 (92.7%) have good knowledge of HIV and combined anti-retroviral therapy with a score of 70.0% and above. A larger proportion of the respondents, 441 (73.4%), had > 95% adherence. Some of the most important reasons giving for missing doses include, “simply forgot” 147 (24.5%), and “wanted to avoid the side-effects of drugs” 33(5.5%). There were remarkable improvements in the immune status of the subjects with an increment in the proportion of the subjects with CD4+ T cells count of greater than 350 cells/mm3 from 33 (5.5%) at therapy initiation to 338 (56.3%) at study period (p<0.0001). Conclusion: The adherence level of 73.4% was low which calls for intervention and improvement. The combined antiretroviral therapy has significantly improved the immune status of the majority of patients which must be sustained. “Simply forgot” was the most important reason for missing doses.